ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Sutro Biopharma Inc

Sutro Biopharma Inc (STRO)

0.9026
0.0643
(7.67%)
0.9026
0.00
( 0.00% )

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.9026
Bid
0.8503
Ask
0.9026
Volume
1
0.00 Day's Range 0.00
0.5231 52 Week Range 5.17
Market Cap
Previous Close
0.9026
Open
-
Last Trade
1
@
0.8739
Last Trade Time
07:09:54
Financial Volume
-
VWAP
-
Average Volume (3m)
1,972,630
Shares Outstanding
84,461,365
Dividend Yield
-
PE Ratio
-0.33
Earnings Per Share (EPS)
-2.69
Revenue
62.04M
Net Profit
-227.46M

About Sutro Biopharma Inc

Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
South San Francisco, California, USA
Founded
-
Sutro Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker STRO. The last closing price for Sutro Biopharma was $0.90. Over the last year, Sutro Biopharma shares have traded in a share price range of $ 0.5231 to $ 5.17.

Sutro Biopharma currently has 84,461,365 shares outstanding. The market capitalization of Sutro Biopharma is $76.23 million. Sutro Biopharma has a price to earnings ratio (PE ratio) of -0.33.

STRO Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.02382.708238507060.87880.98510.82268303370.88913694CS
4-0.3374-27.20967741941.241.240.719717707210.92828259CS
12-0.6474-41.76774193551.551.620.523119726300.88323983CS
26-1.6974-65.28461538462.63.010.523114886771.30720154CS
52-3.3974-79.00930232564.35.170.523110802022.08096126CS
156-3.7974-80.79574468094.78.720.52317970373.62780967CS
260-9.1574-91.02783300210.0628.30.52316423436.84586964CS

STRO - Frequently Asked Questions (FAQ)

What is the current Sutro Biopharma share price?
The current share price of Sutro Biopharma is $ 0.9026
How many Sutro Biopharma shares are in issue?
Sutro Biopharma has 84,461,365 shares in issue
What is the market cap of Sutro Biopharma?
The market capitalisation of Sutro Biopharma is USD 76.23M
What is the 1 year trading range for Sutro Biopharma share price?
Sutro Biopharma has traded in the range of $ 0.5231 to $ 5.17 during the past year
What is the PE ratio of Sutro Biopharma?
The price to earnings ratio of Sutro Biopharma is -0.33
What is the cash to sales ratio of Sutro Biopharma?
The cash to sales ratio of Sutro Biopharma is 1.23
What is the reporting currency for Sutro Biopharma?
Sutro Biopharma reports financial results in USD
What is the latest annual turnover for Sutro Biopharma?
The latest annual turnover of Sutro Biopharma is USD 62.04M
What is the latest annual profit for Sutro Biopharma?
The latest annual profit of Sutro Biopharma is USD -227.46M
What is the registered address of Sutro Biopharma?
The registered address for Sutro Biopharma is 310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
What is the Sutro Biopharma website address?
The website address for Sutro Biopharma is www.sutrobio.com
Which industry sector does Sutro Biopharma operate in?
Sutro Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BLMZBloomZ Inc
$ 0.2331
(73.96%)
57.95M
INEOINNEOVA Holdings Ltd
$ 1.27
(41.92%)
14.4M
RAINRain Enhancement Technologies Holdco Inc
$ 5.35
(26.78%)
1.93k
LTRYLottery com Inc
$ 2.00
(25.00%)
17.36M
BRNSBarinthus Biotherapeutics PLC
$ 1.01
(24.69%)
120
XOSXos Inc
$ 2.55
(-23.22%)
500
HNRGHallador Energy Company
$ 14.75
(-21.67%)
41.5k
BCAXBicara Therapeutics Inc
$ 12.4208
(-20.68%)
5.31k
MTENMingteng International Corporation Inc
$ 10.13
(-18.11%)
63
IMMXImmix Biopharma Inc
$ 2.0124
(-16.50%)
47.74k
BLMZBloomZ Inc
$ 0.2331
(73.96%)
57.95M
PLRZPolyrizon Ltd
$ 0.004
(-4.76%)
37.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 14.25
(-2.53%)
22.43M
HCTIHealthcare Triangle Inc
$ 0.0072
(9.09%)
20.81M
MLGOMicroAlgo Inc
$ 2.29
(5.53%)
18.64M

STRO Discussion

View Posts
glenn1919 glenn1919 3 weeks ago
STRO...........................................https://stockcharts.com/h-sc/ui?s=STRO&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 weeks ago
STRO..........................https://stockcharts.com/h-sc/ui?s=STRO&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 month ago
STRO.................................................https://stockcharts.com/h-sc/ui?s=STRO&p=W&b=5&g=0&id=p86431144783
👍️0
FALCON1 FALCON1 1 month ago
Excellent time to seek "Defensive Stocks" due to economic headwinds caused by tariffs.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176042856

ELTP, an otc gem on the verge of M&A...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175821245
👍️0
Invest-in-America Invest-in-America 5 months ago
STRO: I launched this new iHub board today due to the below-pasted reply I got from GOOGLE's (AI) search routine regarding my following question: "Which (under $5.00) NASDAQ stock is the most likely to SOAR hugely in price on 1-2-25?"

"According to current market analysis, Sutro Biopharma Inc. (STRO), a clinical-stage biopharmaceutical company currently trading under $5, is considered a potential candidate for a significant price jump due to its promising cancer treatment pipeline, particularly its lead drug candidate "luveltamab tazevibulin" currently in mid-phase trials, which could lead to substantial investor interest if clinical trials prove successful; however, investing in any penny stock carries high risk and should be done with thorough research and consideration of potential downsides."

/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
And "TipRanks" gives STRO a "Strong Buy" rating, for what that's worth. (But its Float is 76-Million, which ain't small.)
👍️0

Your Recent History

Delayed Upgrade Clock